Joe Biden Archives

accountable care organizations cost saving

Politics By Nicholas Florko

Oregon wants to get out of covering drugs like Aduhelm in Medicaid

Politics By Rachel Cohrs

Hospital, physician lobbies sue Biden administration over surprise billing regulation

Politics By Nicholas Florko

As Biden touts his effort to cap insulin prices, advocates push for an even more ambitious reform

Politics By Nicholas Florko

Biden’s new Covid plan: more boosters, free home testing, and ‘monoclonal antibody strike teams’

Politics By Maddie Bender

White House delays Covid-19 vaccine mandates for contractors

Politics By Lev Facher

Here’s how Biden can address high drug prices, without help from Congress

Politics By Rachel Cohrs

Pelosi working to gather support for last-minute, last-ditch drug pricing policy

Politics By Rachel Cohrs

Biden abandons his push to lower drug prices

Politics By Nicholas Florko

Is Robert Califf a savvy choice to helm the FDA — again?

Politics By Lev Facher

Here’s who might replace Francis Collins as NIH director

Politics By Nicholas Florko

The government’s Covid-19 response will continue in a shutdown, but health agencies will face major staff shortages

Politics By Lev Facher and Helen Branswell

Biden’s chaotic messaging on Covid-19 boosters is pitting the White House against the government’s scientific advisers

First Opinion By Brook K. Baker

Biden’s global summit Covid-19 targets are woefully inadequate and must be corrected

Politics By Rachel Cohrs and Lev Facher

In a new policy proposal, Biden presses Congress to let Medicare negotiate drug prices

Politics By Lev Facher

Billions in new research funding sparks a lobbying frenzy among patient advocates

Health By Lev Facher

Biden wants $100 rewards for those who get vaccinated against Covid-19 — but there’s little he can do to make it happen

Health By Lev Facher

For the first time ever, Lander’s White House science office will have an entire wing dedicated to health

D.C. Diagnosis By Nicholas Florko

What happened to the FDA’s toughest regulator?

Politics By Lev Facher

NIH’s Francis Collins: For Biden’s new research agency to succeed, it should prepare for some projects to fail

Politics By Lev Facher

Biden to nominate West Virginia’s Rahul Gupta as drug czar

D.C. Diagnosis By Nicholas Florko

Biden wants a drug pricing plan in 45 days. Who’s going to write it?

Health By STAT Staff

When and how will we know if we need Covid-19 booster shots?

Politics By Rachel Cohrs

In a sweeping executive order, Biden endorses importing drugs from Canada and orders a bigger drug pricing plan by late August

drug price controls would limit cancer research

First Opinion By James K. Glassman

Biden won’t end cancer — or any other disease — by importing drug price controls from Europe

Exclusive By Nicholas Florko

Most Read

‘Not a cause for panic’: Biden urges calm in face of Omicron fears

Califf, Biden’s pick to lead FDA, has millions invested in pharma and tech companies

Covid antivirals could be pandemic game-changers. But Americans might struggle to access them

Former DARPA director: Biden’s new science agency should be independent, not an NIH office

‘Late is better than never’: Biden plan to boost U.S. production of Covid vaccines gets mixed reviews

GOP opposition to vaccine mandates extends far beyond Covid-19

Biden taps Califf to head FDA — an agency where he has plenty of unfinished business

Rochelle Walensky said she’d ‘fix’ the CDC, but nine months in, she’s faltering

All Coverage

Oregon wants to get out of covering drugs like Aduhelm in Medicaid

Hospital, physician lobbies sue Biden administration over surprise billing regulation

As Biden touts his effort to cap insulin prices, advocates push for an even more ambitious reform

Biden’s new Covid plan: more boosters, free home testing, and ‘monoclonal antibody strike teams’

White House delays Covid-19 vaccine mandates for contractors

Here’s how Biden can address high drug prices, without help from Congress

Pelosi working to gather support for last-minute, last-ditch drug pricing policy

Biden abandons his push to lower drug prices

Is Robert Califf a savvy choice to helm the FDA — again?

Here’s who might replace Francis Collins as NIH director

The government’s Covid-19 response will continue in a shutdown, but health agencies will face major staff shortages

Biden’s chaotic messaging on Covid-19 boosters is pitting the White House against the government’s scientific advisers

Biden’s global summit Covid-19 targets are woefully inadequate and must be corrected

In a new policy proposal, Biden presses Congress to let Medicare negotiate drug prices

Billions in new research funding sparks a lobbying frenzy among patient advocates

Biden wants $100 rewards for those who get vaccinated against Covid-19 — but there’s little he can do to make it happen

For the first time ever, Lander’s White House science office will have an entire wing dedicated to health

What happened to the FDA’s toughest regulator?

NIH’s Francis Collins: For Biden’s new research agency to succeed, it should prepare for some projects to fail

Biden to nominate West Virginia’s Rahul Gupta as drug czar

Biden wants a drug pricing plan in 45 days. Who’s going to write it?

When and how will we know if we need Covid-19 booster shots?

In a sweeping executive order, Biden endorses importing drugs from Canada and orders a bigger drug pricing plan by late August

Biden won’t end cancer — or any other disease — by importing drug price controls from Europe

Perna set to retire from Warp Speed later this summer